Primary hyperparathyroidism (PHPT) is associated with increased cardiovascu
lar risk, although the mechanisms involved remain unclear. Recent evidence
has shown increased pulse pressure to be a powerful predictor of cardiovasc
ular events. As increases in pulse pressure are due largely to arterial sti
ffening, we measured arterial stiffness in 21 subjects with PHPT (18 women
and 3 men; 46-71 yr old) and 21 age- and sex-matched healthy controls using
pulse wave analysis, a technique that measures peripheral arterial pressur
e waveforms and generates corresponding central aortic waveforms. This allo
ws determination of the augmentation of central pressure resulting from wav
e reflection and augmentation index, a measure of vessel stiffness. Metabol
ic parameters were also measured.
The serum calcium level among PHPT subjects was (mean +/- so) 2.74 +/- 0.14
mmol/L. pulse wave analysis showed that both augmentation and the augmenta
tion index were significantly higher in the PHPT group vs, controls [16 +/-
5 vs. 10 +/- 4 mm Hg (P < 0.001) and 36 +/- 9% vs. 25 +/- 6% (P < 0.001)]
despite comparable brachial systolic pressures between groups (136 +/- 13 v
s. 134 +/- 18 mm Hg). Patients with PHPT had higher fasting serum insulin l
evels [median (range), 15.8 (7.4-39.4) us. 11.6 (5.1-23) mU/L; P < 0.05] an
d triglyceride (1.6 +/- 0.6 us. 1.2 +/- 0.4 mmol/L; P < 0.05), but lower hi
gh density lipoprotein cholesterol (1.4 +/- 0.4 us. 1.6 +/- 0.3 mmol/L; P <
0.05).
These data indicate that subjects with mild PHPT (calcium, < 3.0 mmol/L) ha
ve increased arterial stiffness, as evidenced by higher augmentation of cen
tral aortic pressures. Enhanced vessel stiffness may arise from a combinati
on of structural and functional vascular changes due to hypercalcemia and/o
r metabolic abnormalities. Increased vascular stiffness in subjects with PH
PT may account in part for the increased cardiovascular risk in this group.